DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Visual Field Assessment With Subjects Who Receive Either Lyrica Or Sugar Pills

Information source: Pfizer
Information obtained from ClinicalTrials.gov on February 12, 2009
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Epilepsies, Partial

Intervention: Lyrica (pregabalin) (Drug); placebo (Drug)

Phase: Phase 4

Status: Recruiting

Sponsored by: Pfizer

Official(s) and/or principal investigator(s):
Pfizer CT.gov Call Center, Study Director, Affiliation: Pfizer

Overall contact:
Pfizer CT.gov Call Center, Phone: 1-800-718-1021

Summary

Epileptic partial seizure subjects will be assigned to take either Lyrica 300 mg per day or placebo which is a sugar pill with no active ingredients in it for 3 months. Neither the study doctor or nor the subject knows what he/she has been assigned to. By the end of the treatment the person's visual field test results will be compared to the one test collected at the beginning, prior to taking the study drug to see if there are any changes.

Clinical Details

Official title: Prospective Randomized 12-Week Controlled Study Of Visual Field Change In Subjects With Partial Seizures Receiving Pregabalin Or Placebo

Study design: Treatment, Randomized, Double Blind (Subject, Caregiver), Parallel Assignment, Safety Study

Primary outcome: Visual field changes, if there is any, while comparing before and after the study drug or placebo consumption will be assessed.

Secondary outcome: Visual acuity will be assessed at the beginning and end of the study as well.

Eligibility

Minimum age: 18 Years. Maximum age: 65 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Epilepsy partial seizure subjects

Exclusion Criteria:

- Pre-existing eye diseases

Locations and Contacts

Pfizer CT.gov Call Center, Phone: 1-800-718-1021

Pfizer Investigational Site, Mobile, Alabama 36604, United States; Recruiting

Pfizer Investigational Site, Mobile, Alabama 36608, United States; Recruiting

Pfizer Investigational Site, Little Rock, Arkansas 72205, United States; Not yet recruiting

Pfizer Investigational Site, Irvine, California 92604, United States; Active, not recruiting

Pfizer Investigational Site, Newport Beach, California 92658, United States; Active, not recruiting

Pfizer Investigational Site, Newport Beach, California 92663, United States; Active, not recruiting

Pfizer Investigational Site, Sarasota, Florida 34232, United States; Recruiting

Pfizer Investigational Site, Sarasota, Florida 34239, United States; Recruiting

Pfizer Investigational Site, Atlanta, Georgia 30339, United States; Recruiting

Pfizer Investigational Site, Suwanee, Georgia 30024, United States; Recruiting

Pfizer Investigational Site, Wichita, Kansas 67203, United States; Active, not recruiting

Pfizer Investigational Site, Wichita, Kansas 67208, United States; Active, not recruiting

Pfizer Investigational Site, Wichita, Kansas 67214, United States; Active, not recruiting

Pfizer Investigational Site, Hagerstown, Maryland 21740, United States; Recruiting

Pfizer Investigational Site, Minneapolis, Minnesota 55402, United States; Recruiting

Pfizer Investigational Site, Minneapolis, Minnesota 55422, United States; Recruiting

Pfizer Investigational Site, Columbia, Missouri 65212, United States; Active, not recruiting

Pfizer Investigational Site, Columbia, Missouri 65401, United States; Active, not recruiting

Pfizer Investigational Site, Englewood Cliffs, New Jersey 07632, United States; Active, not recruiting

Pfizer Investigational Site, Paramus, New Jersey 07652, United States; Active, not recruiting

Pfizer Investigational Site, Buffalo, New York 14203, United States; Active, not recruiting

Pfizer Investigational Site, Buffalo, New York 14209, United States; Active, not recruiting

Pfizer Investigational Site, Winston Salem, North Carolina 27103, United States; Active, not recruiting

Pfizer Investigational Site, Winston-Salem, North Carolina 27103, United States; Active, not recruiting

Pfizer Investigational Site, Winston-Salem, North Carolina 27107, United States; Active, not recruiting

Pfizer Investigational Site, Cleveland, Ohio 44195, United States; Not yet recruiting

Pfizer Investigational Site, Cleveland, Ohio 44106, United States; Not yet recruiting

Pfizer Investigational Site, Memphis, Tennessee 38104, United States; Recruiting

Pfizer Investigational Site, Memphis, Tennessee 38163, United States; Recruiting

Pfizer Investigational Site, Longview, Texas 75601, United States; Recruiting

Pfizer Investigational Site, Longview, Texas 75605, United States; Recruiting

Pfizer Investigational Site, Dallas, Texas 75214, United States; Recruiting

Pfizer Investigational Site, Richmond, Virginia 23226, United States; Recruiting

Pfizer Investigational Site, Milwaukee, Wisconsin 53226, United States; Recruiting

Pfizer Investigational Site, Milwaukee, Wisconsin 53226-3522, United States; Recruiting

Additional Information

To obtain contact information for a study center near you, click here.

Starting date: July 2006
Ending date: June 2010
Last updated: January 21, 2009

Page last updated: February 12, 2009

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014